The potential value of CDV3 in the prognosis evaluation in Hepatocellular carcinoma

In conclusion, CDV3 is a biomarker of HCC and could be a potential therapeutic target.
Source: Genes and Diseases - Category: Genetics & Stem Cells Source Type: research